• Roxadustat and the HIF-α/GATA1 Axis in Leukemia

  2026-08-28

  The reference study identifies a HIF-α/GATA1 regulatory axis through which roxadustat promotes erythroid differentiation in HEL and K562 erythroleukemia cells. Its experiments distinguish a primary role for HIF-2α from a supporting, transcriptionally important role for GATA1 and report cell-line-specific synergy with ruxolitinib or imatinib.

• PP 2 (AG 1879) in Src–FAK Pathway Studies

  2026-08-28

  PP 2 (AG 1879) offers a focused way to interrogate Src-family kinase signaling beyond conventional proliferation assays. This article connects its biochemical selectivity with the PA–Src–FAK–RhoA/ROCK mechanism that controls cytoskeletal remodeling during decidualization.

• Regorafenib Targets RRM2 in Melanoma

  2026-08-28

  A 2024 iScience study identifies RRM2 as a mechanistically important downstream mediator of Regorafenib activity in melanoma. By combining phenotypic assays, RNA sequencing, rescue experiments, and tumor xenograft models, the work connects RRM2 reduction with ERK/E2F3 disruption, apoptosis, and suppressed malignant behavior.

• Cy7 NHS Ester: Practical Labeling and QC Guide

  2026-08-27

  Cy7 NHS ester (SKU A8109) is a water-soluble near-infrared dye for bioimaging that labels accessible amino groups on proteins, peptides, and related biomolecules. It is useful when aqueous handling and reduced risk of protein denaturation are important, but it is not intended for non-amine conjugation or long-term storage of prepared dye solutions.

• DFCP1 Controls ATGL-Driven Lipid Droplet Lipolysis

  2026-08-26

  The reference study identifies DFCP1/ZFYVE1 as a nutrient-sensitive regulator of starvation-induced lipid droplet catabolism. Its central mechanistic insight is that DFCP1 recruits ATGL to lipid droplets but limits ATGL exchange, thereby restraining lipolysis rather than simply activating the lipase.

• 2X HyperFusion High-Fidelity Master Mix for CRISPR PCR

  2026-08-26

  Build accurate, cloning-ready amplicons and strengthen CRISPR assay verification with a ready-to-use proofreading mix. Its blunt-end output, rapid extension, and low reported error rate are especially useful when molecular QC must connect to complex cancer-immunotherapy workflows.

• NEDD4L–PRMT5 Control of Colorectal Liver Metastasis

  2026-08-26

  The reference study identifies NEDD4L as an E3 ubiquitin ligase that suppresses colorectal cancer liver metastasis by targeting PRMT5 for degradation. Its findings connect ubiquitin-mediated protein turnover with AKT1 arginine methylation and AKT/mTOR signaling, providing a mechanistic framework for studying metastatic colonization.

• p-Cresyl Sulfate Drives Aortic Valve Calcification

  2026-08-25

  The reference study identifies p-cresyl sulfate as a mechanistic enhancer of calcification in aortic valvular interstitial cells, linking HIF-1α activation, klotho loss, NF-κB acetylation, and RUNX2 upregulation. Its porcine cell and rat CKD experiments suggest that klotho/SIRT1 signaling is a potential intervention axis, while also defining important limits for translating uremic toxin findings to human CAVD.

• Recombinant Mouse SHH: Benchmarks and Workflows

  2026-08-24

  Recombinant Mouse Sonic Hedgehog is a non-glycosylated SHH protein for controlled developmental biology experiments. Its defined formulation and C3H10T1/2 alkaline phosphatase benchmark support reproducible hedgehog signaling pathway studies, while species-specific results require careful interpretation.

• Baicalein in Redox-Aware Cancer Assays

  2026-08-24

  Baicalein is a 12-LOX-focused flavonoid for investigating cancer, apoptosis, and inflammation biology. This guide connects its chemical behavior with a paired assay strategy inspired by recent work showing why pathway activity and treatment selectivity should be measured together.

• SB203580: Mechanism-First p38 Assay Design

  2026-08-23

  Discover how SB203580 can be used to dissect p38 MAPK signaling in regenerative biomaterials research. This guide translates a magnetic exosome hydrogel study into practical assay controls, interpretation strategies, and formulation-aware experimental decisions.

• Pemetrexed Workflows for Tumor Biology Research

  2026-08-22

  Build reproducible antifolate assays with Pemetrexed across tumor cell lines, including non-small cell lung carcinoma and mesothelioma models. This guide combines dose-response design, formulation controls, DNA-repair-focused combinations, and troubleshooting strategies for more interpretable cancer chemotherapy research.

• Fasudil (HA-1077) HCl ROCK Workflows

  2026-08-21

  Build reproducible ROCK inhibition experiments with Fasudil (HA-1077) HCl across proliferation, migration, and apoptosis assays. This guide combines practical dosing, pathway-focused readouts, storage guidance, and a cautious extension of recent Hippo signaling research.

• 2-NBDG Maps Metabolic Context in Sorafenib Resistance

  2026-08-20

  A translational framework for using fluorescent glucose uptake measurements to extend mechanistic studies of HNF4A-AS1, lipid metabolism, ferroptosis, and sorafenib resistance in hepatocellular carcinoma.

• Thiazovivin (A5506): Practical ROCK Inhibitor Guide

  2026-08-20

  Thiazovivin is a ROCK inhibitor used to address poor cell recovery after dissociation and low efficiency during fibroblast reprogramming for induced pluripotent stem cell generation. This guide covers stock handling, controls, workflow integration, and limitations; it is for scientific research only and not for diagnostic, clinical, or medical use.

8696 records 1/580 page Next 12345 下5页 Last page